Ajanta Pharma Ltd Quarterly Results

Gross Sales

1,302.65

1,170.41

1,146.13

1,186.64

1,144.92

Excise Duty

0

0

0

0

0

Net Sales

1,302.65

1,170.41

1,146.13

1,186.64

1,144.92

Other Operating Income

0

0

0

0

0

Other Income

26.33

18.11

30.44

19.48

26.47

Total Income

1,328.98

1,188.52

1,176.57

1,206.12

1,171.39

Total Expenditure

951.3

873.26

825.3

875.47

814.57

PBIDT

377.68

315.26

351.27

330.65

356.82

Interest

5.26

6.07

7.91

6.02

0.73

PBDT

372.42

309.19

343.36

324.63

356.09

Depreciation

41.29

39.78

35.97

34.39

33.97

Minority Interest Before NP

0

0

0

0

0

Tax

73.5

61.96

94.85

76.11

79.38

Deferred Tax

2.29

-17.81

-20.34

-2.35

-3.03

Reported Profit After Tax

255.34

225.26

232.88

216.48

245.77

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

255.34

225.26

232.88

216.48

245.77

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

255.34

225.26

232.88

216.48

245.77

EPS (Unit Curr.)

20.44

18

18.6

17.27

19.54

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

1,400

0

Equity

25.07

25.07

25.07

25.07

25.07

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

28.99

26.93

30.64

27.86

31.16

PBDTM(%)

28.58

26.41

29.95

27.35

31.1

PATM(%)

19.6

19.24

20.31

18.24

21.46